Skip to main content
. 2020 Jul 20;68(2):313–317. doi: 10.1111/tbed.13710

Figure 2.

Figure 2

Cumulative statistics from drug repurposing‐focused COVID‐19 clinical trials, based on the aggregate number of trials (out of a total of 53 publicly reported by 17 April 2020) involving (a) a specific drug, (b) a classifying target or mechanism, (c) clinical research phase, (d) single centre vs. multi‐centre and (e) a given expected timeframe for reporting results